Depreciation of Gain Therapeutics, Inc. from 31 Mar 2020 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Gain Therapeutics, Inc. quarterly and annual Depreciation in USD history and change rate from 31 Mar 2020 to 30 Sep 2025.
  • Gain Therapeutics, Inc. Depreciation for the quarter ending 30 Sep 2025 was $10,000, unchanged year-over-year.
  • Gain Therapeutics, Inc. Depreciation for the twelve months ending 30 Sep 2025 was $40,000.
  • Gain Therapeutics, Inc. annual Depreciation for 2024 was $38,000, a 8.6% increase from 2023.
  • Gain Therapeutics, Inc. annual Depreciation for 2023 was $35,000, a 31% increase from 2022.
  • Gain Therapeutics, Inc. annual Depreciation for 2022 was $26,632, a 72% increase from 2021.
Source SEC data
View on sec.gov
Depreciation, Trailing 12 Months (USD)
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Change (%)
Depreciation, Annual (USD)
Depreciation, YoY Annual Change (%)

Gain Therapeutics, Inc. Quarterly Depreciation (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $40,000 $10,000 $0 0% 01 Jul 2025 30 Sep 2025 10-Q 12 Nov 2025 2025 Q3
Q2 2025 $40,000 $10,000 +$1,000 +11% 01 Apr 2025 30 Jun 2025 10-Q 12 Aug 2025 2025 Q2
Q1 2025 $39,000 $9,000 +$1,000 +12% 01 Jan 2025 31 Mar 2025 10-Q 14 May 2025 2025 Q1
Q4 2024 $38,000 $11,000 01 Oct 2024 31 Dec 2024 10-K 27 Mar 2025 2024 FY
Q3 2024 $10,000 01 Jul 2024 30 Sep 2024 10-Q 12 Nov 2025 2025 Q3
Q2 2024 $9,000 -$8,139 -47% 01 Apr 2024 30 Jun 2024 10-Q 12 Aug 2025 2025 Q2
Q1 2024 $8,000 $0 0% 01 Jan 2024 31 Mar 2024 10-Q 14 May 2025 2025 Q1
Q2 2023 $17,139 +$5,635 +49% 01 Apr 2023 30 Jun 2023 10-Q 10 Aug 2023 2023 Q2
Q1 2023 $8,000 +$2,700 +51% 01 Jan 2023 31 Mar 2023 10-Q 14 May 2024 2024 Q1
Q2 2022 $11,504 01 Apr 2022 30 Jun 2022 10-Q 10 Aug 2023 2023 Q2
Q1 2022 $5,300 +$1,897 +56% 01 Jan 2022 31 Mar 2022 10-Q 12 May 2023 2023 Q1
Q1 2021 $3,403 +$1,302 +62% 01 Jan 2021 31 Mar 2021 10-Q 16 May 2022 2022 Q1
Q1 2020 $2,101 01 Jan 2020 31 Mar 2020 10-Q 10 May 2021 2021 Q1

Gain Therapeutics, Inc. Annual Depreciation (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 $38,000 +$3,000 +8.6% 01 Jan 2024 31 Dec 2024 10-K 27 Mar 2025 2024 FY
2023 $35,000 +$8,368 +31% 01 Jan 2023 31 Dec 2023 10-K 27 Mar 2025 2024 FY
2022 $26,632 +$11,148 +72% 01 Jan 2022 31 Dec 2022 10-K 26 Mar 2024 2023 FY
2021 $15,484 +$5,892 +61% 01 Jan 2021 31 Dec 2021 10-K 23 Mar 2023 2022 FY
2020 $9,592 01 Jan 2020 31 Dec 2020 10-K 25 Mar 2022 2021 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.